Sign in
LHDX Stock Price, Chart, Stats & News
Lucira Health, Inc.
Save
18.36M
Market cap
–
Current P/E
–
Forward P/E
LHDX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 10.99% |
Operating margin | -69.36% |
Pretax margin | -69.65% |
Net margin | -69.67% |
Effective tax rate | -0.03% |
ROA | -26.97% |
ROE | -102.50% |
D/E | 0.01x |
Interest coverage ratio | -21513.33x |
LHDX valuation
P/E | – |
P/S | 0.20x |
P/B | 0.08x |
P/CF | -0.16x |
P/FCF | -0.16x |
P/OCF | -0.16x |
PEG | -0.00x |
EV multiple | -2.01x |
About
Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses.
Similar securities
Based on sector and market capitalization
Report issue